Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-23 Sale |
2024-08-27 6:46 pm |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
164,686 | $5.7814 | $952,116 | 447,530 (Direct) |
View |
| 2021-09-23 Purchase |
2021-09-27 5:22 pm |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer |
4,716 | $7.4757 | $35,255 | 4,716 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-12 Option Award |
2025-02-11 5:54 pm |
N/A 2034-01-12 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
302,500 | $0 | 302,500 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A 2032-01-17 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
157,186 | $0 | 447,530 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
13,125 | $1.81 | 447,530 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
25,000 | $3.27 | 447,530 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
54,895 | $4.85 | 447,530 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
64,166 | $2.49 | 447,530 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:01 pm |
N/A 2033-06-12 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer |
430,000 | $0 | 430,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 5:15 pm |
N/A 2033-02-01 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-07-25 Option Award |
2022-07-27 4:30 pm |
N/A 2032-07-24 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 4:25 pm |
N/A 2032-01-17 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-09-07 Option Award |
2021-09-09 5:21 pm |
N/A 2031-09-06 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 5:47 pm |
N/A 2031-02-10 |
Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks |
67,700 | $0 | 67,700 (Direct) |
View |